Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/15/2012US20120065209 TETRAHYDRO-IMIDAZO[1,5-a]PYRAZINE DERIVATIVES SALTS, PREPARATION METHODS AND MEDICINAL USE THEREOF
03/15/2012US20120065208 Cancer treatment
03/15/2012US20120065207 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065206 Compounds for treating proliferative disorders
03/15/2012US20120065205 Pyrazine carboxamide orexin receptor antagonists
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/15/2012US20120065203 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
03/15/2012US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/15/2012US20120065201 Inhibitors of bruton's tyrosine kinase
03/15/2012US20120065200 Inhibitors of notum pectinacetylesterase and methods of their use
03/15/2012US20120065199 Substituted quinolines for use as vegf inhibitors
03/15/2012US20120065198 Detection and Treatment of Schizophrenia
03/15/2012US20120065196 Amide compounds
03/15/2012US20120065195 Compounds for treating neurodegenerative diseases
03/15/2012US20120065194 Use of cyproheptadine to treat organophosphate exposure
03/15/2012US20120065193 Cyclopropyl Amide Derivatives '978
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065190 Benzazepine compounds as cgrp receptor antagonists
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065188 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/15/2012US20120065187 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/15/2012US20120065186 Antimicrobial compositions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065184 Compounds and compositions as trk inhibitors
03/15/2012US20120065183 Tetrahydro-Pyrido-Pyrimidine Derivatives
03/15/2012US20120065182 Stabilizing compositions for antibiotics and methods of use
03/15/2012US20120065181 Method of providing neuroprotection using substituted porphyrins
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065179 Prodrug comprising beta-keto carboxylic acid, beta-keto carboxylic acid salt or beta-keto carboxylic acid ester for drug delivery
03/15/2012US20120065178 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
03/15/2012US20120065177 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
03/15/2012US20120065176 Treatment of muscle disease characterized by insulin resistance
03/15/2012US20120065175 Method of preparing dry powder inhalation compositions
03/15/2012US20120065174 Compositions of glycopyrronium salt for inhalation
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065172 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
03/15/2012US20120065171 Fostriecin derivatives and the pharmaceutical uses thereof
03/15/2012US20120065170 Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
03/15/2012US20120065169 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
03/15/2012US20120065168 Pharmaceutical Hypocholesterolemic Compositions
03/15/2012US20120065167 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
03/15/2012US20120065166 Bone Modulators And Methods Therewith
03/15/2012US20120065165 Compositions and methods of treating endothelial disorders
03/15/2012US20120065162 N-n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
03/15/2012US20120065161 Cyclodextrin-based polymers for therapeutic delivery
03/15/2012US20120065160 Delivery system for delivery of a substance into the oral cavity
03/15/2012US20120065159 Composition containing chamaecyparis obtusa polysaccharides to be externally applied to the skin
03/15/2012US20120065158 Fucoidan having antitumor activity
03/15/2012US20120065157 Particulate-soluble glucan preparation
03/15/2012US20120065156 Uracyl Spirooxetane Nucleosides
03/15/2012US20120065155 A3 adenoside receptor agonists for the reduction of intraocular pressure
03/15/2012US20120065154 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof
03/15/2012US20120065153 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof
03/15/2012US20120065152 Prodrugs of guanfacine
03/15/2012US20120065151 Substances Mixture, Use and Infusion Solution
03/15/2012US20120065150 Neuroprotective effects of 2DG in Traumatic Brain Injury
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120065147 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
03/15/2012US20120065145 Alkylating agent combinations in the treatment of cancer
03/15/2012US20120065138 Lipids, lipid complexes and use thereof
03/15/2012US20120065125 Methods and compositions for the treatment of cancer or other diseases
03/15/2012US20120065124 Cell-penetrating peptides
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064578 Chromosome-based platforms
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064532 Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
03/15/2012US20120064181 P2X3 Receptor Antagonists for Treatment of Pain
03/15/2012US20120064180 Use of no and no donors for terminating dormancy in invertebrates
03/15/2012US20120064177 Method of preparing an intranasal composition and intranasal compositions obtainable thereby
03/15/2012US20120064175 HSP90 Inhibitors for Treating Non-Small Cell Lung Cancer in Wild-Type EGFR and/or KRAS Patients
03/15/2012US20120064168 Methods of treatment using a gastric retained gabepentin dosage
03/15/2012US20120064167 Modified-release pharmaceutical drug composition
03/15/2012US20120064166 Formulation comprising drospirenone for subcutaneous or intramuscular administration
03/15/2012US20120064165 Treatment of tissue adhesion
03/15/2012US20120064164 Extended release pharmaceutical compositions
03/15/2012US20120064161 Modified release niacin pharmaceutical formulations
03/15/2012US20120064160 Fibrate-statin Combinations with Reduced Fed-fasted Effects
03/15/2012US20120064159 Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
03/15/2012US20120064158 Dissolution properties of drug products containing olmesartan medoxomil
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064156 Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs
03/15/2012US20120064155 Oral pharmaceutical composition for use in respiratory diseases
03/15/2012US20120064154 Solid drug for oral use
03/15/2012US20120064153 Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
03/15/2012US20120064152 Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same
03/15/2012US20120064151 Enhanced immune response in avian species
03/15/2012US20120064146 Wound care device
03/15/2012US20120064145 Wound dressing
03/15/2012US20120064143 Inhibition of mammalian target of rapamycin
03/15/2012US20120064142 Polymeric pharmaceutical dosage form in sustained release
03/15/2012US20120064140 Composite nanogranules from polymer/inorganic nanoparticles, preparation method thereof and use of the same
03/15/2012US20120064139 Antimicrobial sucralfate paste methods and compositions
03/15/2012US20120064136 Anti-aging and wrinkle treatment methods using nanoemulsion compositions
03/15/2012US20120064135 Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
03/15/2012US20120064133 Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
03/15/2012US20120064132 Antibacterial medical equipment and method for producing the same
03/15/2012US20120064130 Method for impregnation with supercritical co2
03/15/2012US20120064129 Gastric retained gabapentin dosage form
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
1 ... 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 ... 7860